Olema Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a sele…

Biotechnology
US, San Francisco [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of OLMA's Analysis
CIK: 1750284 CUSIP: 68062P106 ISIN: US68062P1066 LEI: - UEI: -
Secondary Listings
OLMA has no secondary listings inside our databases.